Skip to main content

Advertisement

Log in

Integrating network pharmacology and experimental models to examine the mechanisms of corosolic acid in preventing hepatocellular carcinoma progression through activation PERK-eIF2a-ATF4 signaling

  • Research
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

Hepatocellular carcinoma (HCC) is the most prevalent form of liver cancer, with a high recurrence rate and heterogeneity. We aimed to examine the effect of corosolic acid (CRA) on HCC. We employed transcriptomics to validate the target molecules in CRA-treated HCC cells and conducted enrichment analyses that revealed their involvement in the regulation of endoplasmic reticulum (ER) stress and apoptosis. Our experimental data indicated that CRA markedly induced apoptosis in human HCC cell lines through the mitochondrial apoptosis pathway. We also revealed that the pro-apoptotic effects of CRA depended on ER stress, as pretreatment with selective ERS inhibitor salubrinal effectively reversed CRA-induced cell apoptosis. Furthermore, the knockdown of the unfolded protein response (UPR) protein CHOP remarkably abrogated CRA-induced expression of ER stress-associated proteins. Collectively, our results suggest that CRA triggers ER stress-mediated apoptosis in HCC cells via activation of the PERK-eIF2a-ATF4 pathway. Our findings provide novel insights into the potential therapeutic strategies for HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Data availability

The original contributions presented in the study are included in the article/Supplementary Material. Further data can be obtained from the corresponding authors upon request.

References

Download references

Acknowledgements

We thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (grant no. 81873150), and the Innovative project of the Health Commission of Shanghai Municipality (ZY (2021-2023)-0203-04).

Author information

Authors and Affiliations

Authors

Contributions

Yanfeng Xu and Feifeng Tang contributed to the conception and design of the study; Feifeng Tang and Yingxiu Peng performed the experiments; Feifeng Tang contributed to the acquisition, analysis, and interpretation of data; Feifeng Tang drafted the manuscript; Yanfeng Xu supervised the project; Jingjin Liu and Wenhui Gao were involved in the investigation; Yanfeng Xu revised the manuscript critically for important intellectual content. All authors have approved the final vision of this manuscript. The authors declare that all data were generated in-house and that no paper mill was used.

Corresponding author

Correspondence to Yanfeng Xu.

Ethics declarations

Ethical approval

As the in vitro experiments were performed on cell lines, approval from the ethics committee was not required for this study.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Tang, F., Peng, Y., Liu, J. et al. Integrating network pharmacology and experimental models to examine the mechanisms of corosolic acid in preventing hepatocellular carcinoma progression through activation PERK-eIF2a-ATF4 signaling. Naunyn-Schmiedeberg's Arch Pharmacol 396, 3671–3682 (2023). https://doi.org/10.1007/s00210-023-02560-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00210-023-02560-z

Keywords

Navigation